Chinese Scientists Achieve Medical Milestone with World’s First Successful Diabetes Reversal Using Stem Cell Therapy
In a groundbreaking achievement that could transform diabetes treatment worldwide, researchers in China have successfully reversed Type 1 diabetes in a patient using her own reprogrammed stem cells—marking the first time in medical history that this autoimmune disease has been functionally cured through cellular therapy.
Last year, cell biologist Deng Hongkui and his team at Peking University in Beijing took cells from a woman with type 1 diabetes, reprogrammed them into blood sugar-regulating cell clusters and injected them back into her abdomen. The revolutionary procedure represented an entirely new approach to treating the condition that affects millions globally.
The results have exceeded all expectations. Two and a half months later, the young woman started producing enough of her own insulin to not need injections of the hormone anymore. Now, more than a year has passed since the treatment, and in another world first, her ability to produce insulin has remained stable. The patient, who remains anonymous, can now enjoy normal foods including sweets—something previously impossible without careful insulin management.
The Revolutionary Process
The treatment involved extracting cells from the patient’s fat tissue and chemically transforming them into pluripotent stem cells—specialized cells capable of developing into any type of tissue. These stem cells were then guided to become insulin-producing islet cells, the very cells that Type 1 diabetes destroys.
The team injected the equivalent of 1.5 million islets into the patient’s abdomen, rather than her liver, where islet transplants are usually injected, allowing researchers to monitor the transplanted cells using MRI imaging and assess their long-term viability.
Addressing a Global Crisis
Type 1 diabetes occurs when the immune system attacks the body’s insulin-producing cells in the pancreas, leading to dangerously high blood sugar levels that require lifelong insulin injections. China currently has the highest number of diabetes cases in the world.
Traditional treatments have included pancreatic transplants, but these are limited by donor availability and require patients to take immunosuppressive drugs permanently. This new approach eliminates both challenges by using the patient’s own cells.
Expanding Success
The breakthrough extends beyond a single case. The trial includes two more patients who were operated on after the woman. Their one year post-treatment mark is coming up in November, but the results are already “very positive,” Deng tells Nature News.
Leading diabetes researchers worldwide have expressed amazement at the results. As one expert noted, using the patient’s own cells means organ rejection isn’t a concern and dramatically reduces the need for anti-rejection medications.
Future Implications
While scaling this treatment globally will present challenges, the success opens unprecedented possibilities for treating diabetes and potentially other autoimmune conditions. The research team plans to expand trials to include more patients, potentially offering hope to millions who currently depend on daily insulin injections for survival.
This medical breakthrough represents not just an advancement in diabetes care, but a fundamental shift toward regenerative medicine that harnesses the body’s own cellular machinery to cure previously incurable diseases.
The Obscure Mirror
